RESUMEN
After the introduction of reverse sequence syphilis screening in Alberta, Canada, there was an increase in the diagnosis of late latent syphilis in individuals screening positive with the treponemal test; these cases required additional public health follow-up.
Asunto(s)
Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Tamizaje Masivo/métodos , Sífilis Latente/enzimología , Treponema pallidum/aislamiento & purificación , Adulto , Alberta/epidemiología , Trazado de Contacto , Femenino , Prueba de Absorción de Anticuerpos Fluorescentes de Treponema/métodos , Humanos , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad , Prevalencia , Sensibilidad y Especificidad , Serodiagnóstico de la Sífilis/métodos , Sífilis Latente/diagnóstico , Sífilis Latente/epidemiologíaRESUMEN
Subcutaneous phaeohyphomycosis is caused by traumatic implantation of melanized environmental fungi. The majority of cases occur in tropical areas of the world or are associated with travel from these regions. Herein, we describe a rare case of subcutaneous phaeohyphomycosis caused by Rhytidhysteron rufulum in an immunocompetent Somalia-born patient. The use of molecular diagnostics as an essential tool for identification of rare fungal pathogens is highlighted.
RESUMEN
We describe an extractionless real-time reverse transcriptase-PCR (rRT-PCR) protocol for SARS-CoV-2 nucleic acid detection using heat as an accurate cost-effective high-capacity solution to COVID-19 testing. We present the effect of temperature, transport media, rRT-PCR mastermixes and gene assays on SARS-CoV-2 gene amplification and limits of detection. Utilizing our heated methodology, our limits of detection were 12.5 and 1 genome copy/reaction for singleplex E- and N1-gene assays, respectively, and 1 genome copy/reaction by utilizing an E/N1 or Orf1ab/N1 multiplex assay combination. Using this approach, we detected up to 98% of COVID-19 positive patient samples analyzed in our various cohorts including a significant percentage of weak positives. Importantly, this extractionless approach will allow for >2-fold increase in testing capacity with existing instruments, circumvent the additional need for expensive extraction devices, provide the sensitivity needed for COVID-19 detection and significantly reduce the turn-around time of reporting COVID-19 test results.